Authors: Monforte, AD Adorni, F Meroni, L Bini, T Testa, L Chiesa, E Melzi, S Rusconi, S Sollima, S Galli, M Moroni, M

Citation: Ad. Monforte et al., Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen, BIOMED PHAR, 55(1), 2001, pp. 16-22

Authors: Bini, T Testa, L Chiesa, E Adorni, F Abeli, C Castelnuovo, B Melzi, S Sollima, S Bongiovanni, M Monforte, AD

Citation: T. Bini et al., Outcome of a second-line protease inhibitor-containing regimen in patientsfailing or intolerant of a first highly active antiretroviral therapy, J ACQ IMM D, 24(2), 2000, pp. 115-122

Authors: Antinori, S Esposito, R Ridolfo, AL Santambrogio, S Sollima, S Moroni, M

Citation: S. Antinori et al., Highly active antiretroviral therapy as an effective treatment for azole-refractory candidiasis, INF DIS C P, 8(8), 1999, pp. 403-407

Authors: Sollima, S Pizzuto, M Bonetto, S Ravasio, L Tosoni, A Vago, L Corbellino, M Antinori, S

Citation: S. Sollima et al., A case of oesophageal leishmaniasis indicating visceral leishmaniasis in apatient with AIDS, EUR J CL M, 18(10), 1999, pp. 752-755

Authors: Monforte, AD Testori, V Adorni, F Castelnuovo, B Bini, T Testa, L Moscatelli, G Chiesa, E Rusconi, S Abeli, C Sollima, S Musicco, M Meroni, L Galli, M Moroni, M

Citation: Ad. Monforte et al., CD4 cell counts at the third month of HAART may predict clinical failure, AIDS, 13(13), 1999, pp. 1669-1676